Medical Doctor Program year 2025 Reported 2022–2025 Source: CMS Open Payments, 2026 publication

Adam Kaufman

Otology & Neurotology Baltimore, MD Medical Doctor

NPI 1114313426 CMS profile 4219659

16 S Eutaw St Ste 500, Baltimore, MD 21201

Open in the dashboard

General payments

$4,181

26 records reported · program years 2022–2025

Research payments

$0

Paid to them · None reported · program years 2022–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Adam Kaufman of Baltimore, MD is reported in the CMS Open Payments database as having received $4,181 across 26 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 66th percentile of Otology & Neurotology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,766 7
2024 General $370 4
2023 General $267 2
2022 General $778 13

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Adam Kaufman
  • Otology & Neurotology median
  • Middle half of Otology & Neurotology
  • National median

In program year 2025, general payments to Adam Kaufman were reported at $2,766. Among 280 Otology & Neurotology profiles paid that year, the median was $411 and the middle half received between $148 and $1,608.

Show as a table
Year Adam Kaufman Otology & Neurotology median Middle half National median
2019 $0 $349 $117–$1,358 $163
2020 $0 $118 $58–$325 $114
2021 $0 $186 $81–$600 $132
2022 $778 $290 $129–$938 $149
2023 $267 $335 $119–$978 $160
2024 $370 $399 $138–$1,384 $164
2025 $2,766 $411 $148–$1,608 $169

Breakdown

Who paid General payments · program years 2022–2025
  1. Ambu A/S $2,000 1 payment
  2. Stryker Corporation $891 6 payments
  3. Cochlear Americas $846 11 payments
  4. Integra LifeSciences Corporation $215 3 payments
  5. Inspire Medical Systems, Inc. $140 1 payment
  6. Advanced Bionics, LLC $64 3 payments
  7. Reliance Medical Products, Inc. $25 1 payment

Every payment, record by record

What the payments were for General payments · program years 2022–2025
  1. Honoraria $2,000 1 payment
  2. Food and Beverage $1,752 22 payments
  3. Travel and Lodging $404 2 payments
  4. Gift $25 1 payment
Products named General payments · program years 2022–2025
  1. BAHA $846 11 payments
  2. Cochlear Implantable hearing solution $714 10 payments
  3. Cochlear Implantable hearing solution $714 10 payments
  4. NA Neuro $424 3 payments
  5. DURAMATRIX $316 2 payments
  6. ADHERUS AUTOSPRAY ET DURAL SEALANT $316 2 payments
  7. DIRECT INJECT $316 2 payments
  8. NA Craniomaxillofacial $243 2 payments
  9. NA Craniomaxillofacial $243 2 payments
  10. ACCLARENT AERA $215 3 payments
  11. Other $2,245 23 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 28 billing codes

Paid by Medicare

$18,355

Medicare's payments for the services billed

Medicare patients

79

Average age 69

Services billed

156

37 women, 42 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Diabetes 42%
Ischemic heart disease 35%
Chronic kidney disease 35%
Arthritis 32%
COPD 22%
Heart failure 20%
Depression 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

26 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Otology & Neurotology in Maryland

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record